- Home
- MRK vs NVVEW Comparison
MRK vs NVVEW Comparison
Compare MRK & NVVEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- NVVEW
- Stock Information
- Founded
- MRK 2000
- NVVEW N/A
- Country
- MRK United States
- NVVEW China
- Employees
- MRK N/A
- NVVEW 12
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- NVVEW Oil Refining/Marketing
- Sector
- MRK Health Care
- NVVEW Energy
- Exchange
- MRK Nasdaq
- NVVEW Nasdaq
- Market Cap
- MRK 218.8B
- NVVEW N/A
- IPO Year
- MRK N/A
- NVVEW 2020
- Fundamental
- Price
- MRK $85.91
- NVVEW $0.02
- Analyst Decision
- MRK Buy
- NVVEW
- Analyst Count
- MRK 14
- NVVEW 0
- Target Price
- MRK $103.54
- NVVEW N/A
- AVG Volume (30 Days)
- MRK 14.1M
- NVVEW N/A
- Earning Date
- MRK 10-30-2025
- NVVEW N/A
- Dividend Yield
- MRK 3.77%
- NVVEW N/A
- EPS Growth
- MRK 20.41
- NVVEW N/A
- EPS
- MRK 6.49
- NVVEW N/A
- Revenue
- MRK $63,616,000,000.00
- NVVEW N/A
- Revenue This Year
- MRK $1.84
- NVVEW N/A
- Revenue Next Year
- MRK $5.24
- NVVEW N/A
- P/E Ratio
- MRK $13.26
- NVVEW N/A
- Revenue Growth
- MRK 1.82
- NVVEW N/A
- 52 Week Low
- MRK $73.31
- NVVEW N/A
- 52 Week High
- MRK $111.58
- NVVEW N/A
- Technical
- Relative Strength Index (RSI)
- MRK 54.14
- NVVEW 51.72
- Support Level
- MRK $86.20
- NVVEW $0.02
- Resistance Level
- MRK $88.24
- NVVEW $0.02
- Average True Range (ATR)
- MRK 2.25
- NVVEW 0.00
- MACD
- MRK 0.28
- NVVEW 0.00
- Stochastic Oscillator
- MRK 61.55
- NVVEW 79.55
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About NVVEW Nuvve Holding Corp. Warrant
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.